DISCLAIMER - ( Please read and accept the disclaimer below to continue ).
The M. D. Anderson Cancer Center Oral History Project is a repository for the stories, accounts, and memories of those who have chosen to share their experiences. The viewpoints expressed in the M. D. Anderson Cancer Center Oral History Project do not necessarily represent the viewpoints of M. D. Anderson Cancer Center or any of its officers, agents, employees, or volunteers. M. D. Anderson Cancer Center makes no warranty as to the accuracy or completeness of any information contained in the interviews and expressly disclaim any liability therefore.
M. D. Anderson Cancer Center retains the literary and publishing rights of its oral histories. No part of the interviews or transcripts may be published without the written permission of the M. D. Anderson Cancer Center Oral History Project.
Requests for permission to quote for publication should be addressed to:
M. D. Anderson Cancer Center Oral History Project
Research Medical Library - Unit 1499
The University of Texas M. D. Anderson Cancer Center
P.O. Box 301402
Houston, Texas 77230-1402
The M. D. Anderson Cancer Center Oral History Project reserves the right, in its sole discretion, to decline to post any account received herein and specifically disclaims any liability for the failure to post an account or for errors or omissions that may occur in posting accounts to the Virtual Archive.
For more information email the M. D. Anderson Cancer Center Oral History Project at email@example.com .
|Collection:||Making Cancer History Voices Oral History Collection|
|Interviewee:||Freireich, Emil J., 1927-|
|Interviewer:||Brunet, Lesley W.|
|Title:||Emil J. Freireich, M.D. Oral History Interview Portions|
|Date:||July 23, 2001; July 30, 2001; August 13, 2001|
|Abstract:||Several of Dr. Emil Freireich’s significant accomplishments are highlighted regarding his early research and educational interests. The first clip describes some of his early studies concerning platelets and platelet-rich plasma while stationed at the National Cancer Institute. The second clip highlights some of his early work regarding combination chemotherapy as applied to the management of childhood leukemia. The final clip details several of his educational interests and activities at the University of Texas M.D. Anderson Cancer Center.|
|Format:||1 streaming video file and 1 interview transcript|
|Interview Length:||25 minutes|
|Language:||Materials are in English|
|Repository:||Historical Resources Center, Research Medical Library, The University of Texas MD Anderson Cancer Center|
Born in Chicago, Illinois in 1927, Dr. Emil J. Freireich earned his medical degree from the University of Illinois, College of Medicine in 1949. After serving as a research associate in Hematology at Massachusetts Memorial Hospital, Dr. Freireich spent ten years at the National Cancer Institute in Bethesda, Maryland where he is credited with numerous revolutionary discoveries in the field of leukemia research. In 1965, Dr. Freireich joined the faculty at the University of Texas, M.D. Anderson Cancer Center as Professor of Medicine where he has contributed to many pioneering and innovative advancements in the field of oncology. Dr. Freireich was named director of the Adult Leukemia Research Program in 1985 and director of the Special Medical Education Programs in 2000. Dr. Freireich also serves as professor in the departments of Leukemia and Laboratory Medicine.
|Restrictions on Access:||Portions of this interview have been redacted for privacy concerns. Please see Archivist for details.|
|Restrictions on Use:||
All requests for copying of materials must be submitted to the Historical Resources Center in writing for approval. All reproductions will be handled by HRC staff.Authorization to publish, quote, or reproduce must be obtained in writing by the Historical Resources Center.
Freireich, Emil J., 1927-
Zubrod, C. Gordon (Charles Gordon), 1914-
|Subjects (Organizations):||National Cancer Institute (NCI)
University of Texas M.D. Anderson Cancer Center -- history
Clinical Trials as Topic
Leukemia -- drug therapy
|Provenance:||Interview with Emil J. Freireich, M.D. conducted by Lesley W. Brunet|
|Preferred Citation:||Emil J. Freicreich, M.D. Oral History Interview Portions, July 23, 2001; July 30, 2001; August 13, 2001, Research Medical Library, The University of Texas M. D. Anderson Cancer Center.|
|Processing Information:||Oral history was edited by Michele Wilson, HRC Intern, Summer 2011.|